ClinicalTrialsFinder

B-cell Lymphoma Refractory Clinical Trials in Nanchang, Jiangxi

1 recruitingNanchang, Jiangxi, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL

Acute Lymphoblastic Leukemia, in RelapseB-cell Lymphoma RecurrentB-cell Lymphoma Refractory+1 more
Rong Tao48 enrolled2 locationsNCT06445803